Counterfeit ACT poses malaria resistance risk
Counterfeit ACT could support the spread of drug resistant malaria strains from South-East Asia, where chloroquine first became ineffective, to sub-Saharan Africa.
Archives for December 2, 2010
bioMérieux exits Portland site production of prepared media, resulting job losses
bioMérieux will discontinue manufacturing media products for clinical applications and transfer production of other products made at its Portland, US, site elsewhere as part of a restructuring program.
Metrics launches video monitoring service ‘PharmaVision’
CDMO Metrics has launched “PharmaVision,” a video monitoring service which will enable clients to oversee onsite production procedures.
Multiple strategies needed to beat counterfeiters
Only multiple anti-counterfeiting strategies are able to beat increasingly sophisticated criminals, according to a seminar on anti-counterfeiting at the recent AAPS trade event in New Orleans.
Guidelines needed for inconsistent OTC medication dosing warnings, urge researchers
Mandatory guidelines for labelling of OTC liquid medication for children should be issued, said researchers who found major inconsistencies in labels and dosage measuring devices.
Complex supply chain driving shift in analytical methods
The shift towards a complex global supply chain incorporating many suppliers and service providers is driving adoption of modern analytical methods to ensure quality.
Patheon begins search for new CEO
US CMO Patheon has begun the search for a new CEO after the departure of former chief, Wes Wheeler.
Beximco inks manufacture & supply deal to target US
Beximco Pharmaceuticals has inked a manufacturing, supply and development deal with Adamis Pharmaceuticals to introduce generics to the US.
MPI Research accused of mistreating animals during preclinical research
Animal welfare watchdog group, Stop Animal Exploitation Now (SAEN), has released documents which, it claims, provide evidence that CRO MPI Research has been operating in violation of the US Animal Welfare Act.